SlideShare a Scribd company logo
Resilience and PRRS in a natural
disease challenge model
Graham Plastow
University of Alberta
Chicago, December 2nd 2017
Application of Genomics to Improve
Disease Resilience and Sustainability
in Pork Production
Project Leaders: Michael Dyck (U Alberta), John Harding
(U Saskatchewan), Bob Kemp (PigGen Canada)
Application of Genomics to Improve
Disease Resilience and Sustainability
in Pork Production
Project Leaders: Michael Dyck (U Alberta), John Harding
(U Saskatchewan), Bob Kemp (PigGen Canada)
Includes several components
Vaccine response
Salmonella challenge (Ab/Microbiome)
Nutrition & Gut Health (Microbiome)
PRRSV Pregnant Gilt Challenge e.g. Vet. Micro. 209: 114-123 (2017)
Organoid models
and Natural Challenge Model
A Natural Challenge Model
for Disease Resilience in Pigs
Jack Dekkers, John Harding, Frederic Fortin, PigGen
Canada, Michael Dyck, Graham Plastow
Andrea Wilson, Bonnie Mallard, Claire Rogel-Gaillard,
Ben Willing, Catherine Field
Austin Putz, Jiehan Lim, Ziqi Yang
What is Resilience?
• Definition of Resilience…..
– “the capacity to recover quickly from difficulties;
toughness.” Oxford Dictionary https://en.oxforddictionaries.com
• Disease Resilience…..
– combination of resistance and tolerance to
diseases….animal’s ability to remain productive
despite being disease-challenged
– The ability of pigs to respond to pathogens in
a way that minimizes the impact of disease
•Objectives
1. Establish a natural challenge model for grow-finish pigs
2. Determine the genetic basis of disease resilience in pigs
3. Develop predictors of resilience that can be obtained at a
young age in a high-health bio-secure environment
A Natural Challenge Model
for Disease Resilience in Pigs
• PRRS is the most significant disease but it is not only
PRRSV
• Numerous other pathogens are commonly isolated along
with PRRS virus from affected nursery or finishing pigs.
Other bacteria such as Streptococcus suis, Escherichia
coli, Salmonella cholerasuis, Haemophilus parasuis,
and Mycoplasma hyopneumoniae have been reported, as
well as viruses such as porcine respiratory coronavirus
and swine influenza virus.
Dee, Merck Veterinary Manual,
http://www.merckvetmanual.com/generalized-conditions/porcine-reproductive-and-
respiratory-syndrome/overview-of-porcine-reproductive-and-respiratory-syndrome
Motivation?
Health is the Biggest Opportunity for
Animal Genomics
 zoonoses (60% of EIDs)
Adapted from a slide by Dan Barreda The British Pig Association
http://www.britishpigs.org.uk/modern2.htm
High health
Lower health
Selection for genetic
potential for disease
resilience
Health & Growth
Performance
?
INTRODUCTION
• Established by introducing selected “seeder pigs” from
different commercial farms with first few batches
entering the model
• Continuous flow
• Each batch from a single company/herd
• All are LW*LR barrows from high health herds
• Weaned and transported to acclimation unit where
samples are collected prior to challenge
Natural Challenge (Pig & Sample Flow)
60-75 LW/LR barrows/batch High
Health Multiplier Farm weaned - 21
days old
transported
Nursery 1 (2 weeks)
Quarantine and acclimatization
CDPQ Test Station (4 weeks)
Nursery
CDPQ Test Station (16 weeks)
Grower & finisher
transferred
Severity of disease challenge
Clean
Mild
challenge
Severe
challenge
Natural Challenge (Pig & Sample Flow)
Blood 1 – 26 day-old
Blood 3 – 56 days
(Week 2 post-exposure)
Blood 4 – 84 days
(Week 6 post-exposure)
Exposure to seeder
pigs at 42 days
DNA Samples -
Genotyping
660,000 SNPs
Target 3,300
pigs
N Cook, Alberta Agriculture & Forestry, Lacombe
J-P Laforest, Université Laval F Fortin, CDPQ, QC
Natural Challenge (Pig & Sample Flow)
60-75 barrows/batch from
High Health Multiplier Farm
Weaned at 21 days old
transported
CRSAD Building
(3 weeks)
Nursery I
D26 – Blood 1
D42 – Blood 2 &
exit Nursery I
CDPQ Test Station
(4 weeks)
Nursery II
D56 – Blood 3
CDPQ Test Station (16 weeks)
Grower & Finisher
D86 – Blood 4
D120B1-8/D166B9-on – Blood 5
transferred
Blood Samples collected
1 HIR, DRAA, CBC, WBT, Serology
2 HIR, Serology, microbiome
3 CBC, Nab, IgG, WBT, microbiome
4
CBC, IgG, WBT, Serology,
microbiome
5 Serology
6 WBT, Serology (sick & healthy)
Overview - Data
Quarantine
Nursery
Immune Response
•HIR
•DRAA
•CBC
•Blood Stimulation
•Phagocytosis
Blood Transcriptome
Blood Metabolome
Blood Proteome
Gut Microbiome
Natural
Challenge
Facility
Growth
Feed/ Water Intake
Mortality/Morbidity
Carcass/Ultrasound
Disease Diagnostics
Blood Transcriptome
Gut Microbiome
March 14, 2017 Midwest 2017 14
Deliverables
Phenotypic
Prediction
of
Resilience
Genetic
Prediction
of
Resilience
Trait:
• Parameters
• Architecture
• Mechanisms
Integrated statistical and
bioinformatic analyses
Putz, A.M., Harding, J.C.S., Fortin, F.,
Plastow, G., Dekkers, J.C.M. (2017) A
natural challenge model for disease
resilience in wean-to-finish pigs. ASAS
MidWest Meeting March 2017. J.
Anim. Sci 95: supplement2, p.17.
Sample
bank
Diseases
March 14, 2017 Midwest 2017 15
Adapted from Dr. John Harding
Lung lesion (Mycoplasma
hyopneumoniae, complicated
with PRRS & Streptococcus
suis)
Lung lesion
(chronic stage of
PRRS in grower)
Lung lesion (Haemophilus
parasuis in grower)
Types of lung lesion found in dead pigs with respiratory signs
NATURAL CHALLENGE
Jiehan Lim
Mortality Reasons %
Lameness 10
Coughing 11
Unthrifty 5
Diarrhea red 1
grey/brown 19
yellow 7
Dermatitis 4
CNS 3
Respiratory 31
Arthritis 5
Inappetance 2
Cyanosis 2
Example Growth Curves
# health
treatments
Blood
1
Blood
3
Blood
4
Disease exposure
Average Mortality at
78 ± 2.3 days
Predicting which Pigs are Resilient ?
Immune Response Measures
• Complete Blood Counts (UAlberta)
‒ CBC = Evaluates white blood cells, leukocytes, B cells,
monocytes and acute phase proteins in pigs
• High Immune Response Assay (UGuelph)
‒ HIR = Assesses adaptive immune response in pigs including:
antibody-mediated and cell-mediated immune responses
• Disease Resistance Assay for Animals (ULaval; USask)
‒ DRAA = Assess immune competence in pigs based on
proliferation of peripheral blood mononuclear cells in pigs
after stimulation by mitogens
‒ Total Immunoglobulin (IgG) & Natural antibodies (NAb) ELISA
• Blood Transcriptome (UAlberta)
Resilience Phenotype
• Treatments
• Disease diagnosis (qualitative)
• Mortality
• Growth
• Feed Intake
• Water Intake
• Blood Transcriptome (Blood 3 and 4)
Austin Putz
Example Feed Intake Curves
Poster
#63
Trait h2
Growth Nursery 0.45 + 0.07
Finish 0.26 + 0.07
Feed Intake 0.33 + 0.07
Gain/Feed 0.35 + 0.07
RFI 0.43 + 0.07
Treatments 0.14 + 0.07
Mortality Liability 0.26 + 0.07
Carcass Wt 0.31 + 0.07
Destron BF 0.52 + 0.08
Destron LD 0.40 + 0.08
Lean Yield 0.39 + 0.09
Trait Heritabilities
Daily Fluctuation in FI as a Measure of Resilience
Austin Putz
Trait
rg with
MSE of FI
Growth Finish -0.31 + 0.27
# Treatments 0.56 + 0.20
Mortality Liability 0.54 + 0.36
MSE of FI
h2 = 0.22+ 0.07
• A natural challenge model for characterization of
disease resilience in pigs has been successfully
established
Conclusions 1
• MSE of FI shows promise as a measure of
resilience.
• Heritable variation in growth, feed intake curves, mortality,
morbidity
3300 YXLR WEANER PIGS
FROM HIGH-HEALTH HERDS
BATCHES OF 60-75 PIGS/3 WEEKS
650K SNP
genotypes
Trait Genetics
• Parameters
• Architecture
• Mechanisms
Genetic
Prediction
of Resilience
Phenotypic
Prediction
of Resilience
PROJECT
DELIVE-
RABLES
Potential BIOMARKERS
collected on
young healthy pigs
Immune Response
• High Immune Response
• In vitro immune tests
• Phagocytosis tests
Blood Transcriptome
Blood Metabolome
Blood Proteome
Gut Microbiome
Integrated
statistical and
bioinformatic
analyses
NATURAL CHALLENGE FACILITYQUARANTINE NURSERY
Continuous flow RESILIENCE PHENOTYPES
Mortality/Morbidity
Growth performance
Feed intake
Water intake
Disease diagnostics
Blood transcriptome
Gut Microbiome
Health treatments
•Example - Complete Blood Counts (CBC)
•Complete Blood Counts (CBC)
Number of treatments
Some initial
results
Difference in
neutrophil/
lymphocyte %
between R and S
Deads not
different
at Bleed 1
Neutrophil %
Lymphocyte %
abab
a bab
Resilient vs Susceptible
samples selected for qPCR
Class Count Bleed 1 Bleed 2 Bleed 3
Resistant Neutrophils 4.8 12.1 9.4
Susceptible Neutrophils 3.8 14.0 13.5
Resistant Lymphocytes 6.3 7.8 9.4
Susceptible Lymphocytes 7.1 8.0 7.4
Resistant N/L 0.77 1.57 1.12
Susceptible N/L 0.55 1.86 1.91
Using CBC for Prediction of Outcome
Cycle 1 (n=391) predicts Cycle 2 (n=397) including dead
Stepwise model accuracy 68.8%
Predicted Resilient pigs in Cycle 2
Actual Resilient 40% versus 29% in Predicted Susceptible
Grow 25g/day faster (all included)
Ave treatment rate 0.5x less
Mortality 0% versus 13%
Work in progress – results highly dependent on assumptions
and classification of resilient pigs in the training set.
Blood Transcriptome and Resilience
Differentially expressed
genes identified in three
different environments
“predicting outcome”
NC1
Genome dx.doi.org/10.1139/gen-2017-0074
• A natural challenge model for characterization of
disease resilience in pigs has been successfully
established
Conclusions 2
• Initial CBC shows initial promise as a predictor of
phenotypic resilience.
• Test different predictors with MSE of FI.
• Genetic analysis, GWAS (660k)……………….
Next?
• Complete data collection (3,300 from 2,000 today)
• Integrate analyses
• Explore blood transcriptome (3’RNAseq), metabolome
and proteome on 960 samples (14 batches) (USDA NIFA)
• Explore infectivity (Andrea Wilson, RI)
• The effect of environmental enrichment on the immune
response and measures of disease resilience and welfare
in pigs. (Yolande Seddon, U of SK)
• Other opportunities – e.g. pen-side diagnostics
33
Thanks!
Partnerships:
UofA Team +

More Related Content

What's hot

Dr Susan E Caldwell Publication Samples
Dr Susan E Caldwell Publication SamplesDr Susan E Caldwell Publication Samples
Dr Susan E Caldwell Publication Samples
Susan E Caldwell, PhD
 
6.epidemiology and management of brd in dairy heifer replacements
6.epidemiology and management of brd in dairy heifer replacements6.epidemiology and management of brd in dairy heifer replacements
6.epidemiology and management of brd in dairy heifer replacementsMerial EMEA
 
Dr. Esteban Domingo: Respuesta del virus de la hepatitis C a inhibidores. Inf...
Dr. Esteban Domingo: Respuesta del virus de la hepatitis C a inhibidores. Inf...Dr. Esteban Domingo: Respuesta del virus de la hepatitis C a inhibidores. Inf...
Dr. Esteban Domingo: Respuesta del virus de la hepatitis C a inhibidores. Inf...
Vall d'Hebron Institute of Research (VHIR)
 
Case studies of HTS / NGS applications
Case studies of HTS / NGS applicationsCase studies of HTS / NGS applications
Case studies of HTS / NGS applications
rjorton
 
Aeras schofield 21112013
Aeras schofield 21112013Aeras schofield 21112013
Aeras schofield 21112013AerasGlobalTB
 
Presentacion 1 cs protein y ratones
Presentacion  1 cs protein y ratonesPresentacion  1 cs protein y ratones
Presentacion 1 cs protein y ratonespaitocaro
 
Association of human leukocyte antigen class II allele and haplotypes Trans R...
Association of human leukocyte antigen class II allele and haplotypes Trans R...Association of human leukocyte antigen class II allele and haplotypes Trans R...
Association of human leukocyte antigen class II allele and haplotypes Trans R...Subrat Thanapati
 
New technologies for manufacturing recombinant products in embryonated eggs
New technologies for manufacturing recombinant products in embryonated eggsNew technologies for manufacturing recombinant products in embryonated eggs
New technologies for manufacturing recombinant products in embryonated eggs
Eluemuno R Blyden
 
Resoso PRRS
Resoso PRRSResoso PRRS
Resoso PRRS
Perez Eric
 
J. Virol.-2012-Qureshi-2239-50
J. Virol.-2012-Qureshi-2239-50J. Virol.-2012-Qureshi-2239-50
J. Virol.-2012-Qureshi-2239-50Huma Qureshi
 
Bacteriospermia
Bacteriospermia  Bacteriospermia
Heme conf 10 08-2015 - dr cho
Heme conf 10 08-2015 - dr  choHeme conf 10 08-2015 - dr  cho
Heme conf 10 08-2015 - dr choderosaMSKCC
 
Hospital Microbiome Project Proposal
Hospital Microbiome Project ProposalHospital Microbiome Project Proposal
Hospital Microbiome Project Proposal
dansmith01
 
New developments in vaccines against African swine fever
New developments in vaccines against African swine feverNew developments in vaccines against African swine fever
New developments in vaccines against African swine fever
ILRI
 
1-s2.0-S0021997515000055-main
1-s2.0-S0021997515000055-main1-s2.0-S0021997515000055-main
1-s2.0-S0021997515000055-mainAlison Lee
 
Research poster 2015
Research poster 2015Research poster 2015
Research poster 2015Sheila Njau
 
Disease State Plasma Newsflash - August 2014 - BBI Solutions
Disease State Plasma Newsflash - August 2014 - BBI SolutionsDisease State Plasma Newsflash - August 2014 - BBI Solutions
Disease State Plasma Newsflash - August 2014 - BBI Solutions
BBISolutions
 
Break through in biochemistry biotechnology[616]
Break through in biochemistry biotechnology[616]Break through in biochemistry biotechnology[616]
Break through in biochemistry biotechnology[616]
Dr.K Madhuri
 
Crispr
CrisprCrispr
Crispr
gistaiwan
 

What's hot (20)

Dr Susan E Caldwell Publication Samples
Dr Susan E Caldwell Publication SamplesDr Susan E Caldwell Publication Samples
Dr Susan E Caldwell Publication Samples
 
6.epidemiology and management of brd in dairy heifer replacements
6.epidemiology and management of brd in dairy heifer replacements6.epidemiology and management of brd in dairy heifer replacements
6.epidemiology and management of brd in dairy heifer replacements
 
Dr. Esteban Domingo: Respuesta del virus de la hepatitis C a inhibidores. Inf...
Dr. Esteban Domingo: Respuesta del virus de la hepatitis C a inhibidores. Inf...Dr. Esteban Domingo: Respuesta del virus de la hepatitis C a inhibidores. Inf...
Dr. Esteban Domingo: Respuesta del virus de la hepatitis C a inhibidores. Inf...
 
Case studies of HTS / NGS applications
Case studies of HTS / NGS applicationsCase studies of HTS / NGS applications
Case studies of HTS / NGS applications
 
Aeras schofield 21112013
Aeras schofield 21112013Aeras schofield 21112013
Aeras schofield 21112013
 
Presentacion 1 cs protein y ratones
Presentacion  1 cs protein y ratonesPresentacion  1 cs protein y ratones
Presentacion 1 cs protein y ratones
 
Association of human leukocyte antigen class II allele and haplotypes Trans R...
Association of human leukocyte antigen class II allele and haplotypes Trans R...Association of human leukocyte antigen class II allele and haplotypes Trans R...
Association of human leukocyte antigen class II allele and haplotypes Trans R...
 
New technologies for manufacturing recombinant products in embryonated eggs
New technologies for manufacturing recombinant products in embryonated eggsNew technologies for manufacturing recombinant products in embryonated eggs
New technologies for manufacturing recombinant products in embryonated eggs
 
Resoso PRRS
Resoso PRRSResoso PRRS
Resoso PRRS
 
J. Virol.-2012-Qureshi-2239-50
J. Virol.-2012-Qureshi-2239-50J. Virol.-2012-Qureshi-2239-50
J. Virol.-2012-Qureshi-2239-50
 
Bacteriospermia
Bacteriospermia  Bacteriospermia
Bacteriospermia
 
Heme conf 10 08-2015 - dr cho
Heme conf 10 08-2015 - dr  choHeme conf 10 08-2015 - dr  cho
Heme conf 10 08-2015 - dr cho
 
논문6
논문6논문6
논문6
 
Hospital Microbiome Project Proposal
Hospital Microbiome Project ProposalHospital Microbiome Project Proposal
Hospital Microbiome Project Proposal
 
New developments in vaccines against African swine fever
New developments in vaccines against African swine feverNew developments in vaccines against African swine fever
New developments in vaccines against African swine fever
 
1-s2.0-S0021997515000055-main
1-s2.0-S0021997515000055-main1-s2.0-S0021997515000055-main
1-s2.0-S0021997515000055-main
 
Research poster 2015
Research poster 2015Research poster 2015
Research poster 2015
 
Disease State Plasma Newsflash - August 2014 - BBI Solutions
Disease State Plasma Newsflash - August 2014 - BBI SolutionsDisease State Plasma Newsflash - August 2014 - BBI Solutions
Disease State Plasma Newsflash - August 2014 - BBI Solutions
 
Break through in biochemistry biotechnology[616]
Break through in biochemistry biotechnology[616]Break through in biochemistry biotechnology[616]
Break through in biochemistry biotechnology[616]
 
Crispr
CrisprCrispr
Crispr
 

Similar to Dr. Graham Plastow - Resilience and PRRS in a natural disease challenge model

Dr. Jack Dekkers and Dr. Bob Rowland - Introduction of the Program
Dr. Jack Dekkers and Dr. Bob Rowland - Introduction of the ProgramDr. Jack Dekkers and Dr. Bob Rowland - Introduction of the Program
Dr. Jack Dekkers and Dr. Bob Rowland - Introduction of the Program
John Blue
 
Dr. Jack Dekkers - Using genetic selection and genomics to combat infectious ...
Dr. Jack Dekkers - Using genetic selection and genomics to combat infectious ...Dr. Jack Dekkers - Using genetic selection and genomics to combat infectious ...
Dr. Jack Dekkers - Using genetic selection and genomics to combat infectious ...
John Blue
 
Dr. Jack Dekkers - Genetics of Host Resistance to PRRS and PCV2
Dr. Jack Dekkers - Genetics of Host Resistance to PRRS and PCV2Dr. Jack Dekkers - Genetics of Host Resistance to PRRS and PCV2
Dr. Jack Dekkers - Genetics of Host Resistance to PRRS and PCV2
John Blue
 
Dr. Andrea Wilson - New PRRS disease phenotypes as vaccine and genetic improv...
Dr. Andrea Wilson - New PRRS disease phenotypes as vaccine and genetic improv...Dr. Andrea Wilson - New PRRS disease phenotypes as vaccine and genetic improv...
Dr. Andrea Wilson - New PRRS disease phenotypes as vaccine and genetic improv...
John Blue
 
Developing diagnostic test for plant, human and animal diseases
Developing diagnostic test for plant, human and animal diseasesDeveloping diagnostic test for plant, human and animal diseases
Developing diagnostic test for plant, human and animal diseases
Sushant Balasaheb Jadhav
 
A Vaccine Approach against HIV-1, Manufacturing Env proteins: from Bench to B...
A Vaccine Approach against HIV-1, Manufacturing Env proteins: from Bench to B...A Vaccine Approach against HIV-1, Manufacturing Env proteins: from Bench to B...
A Vaccine Approach against HIV-1, Manufacturing Env proteins: from Bench to B...
KBI Biopharma
 
Cancer vaccine from mice to humans
Cancer vaccine from mice to humansCancer vaccine from mice to humans
Cancer vaccine from mice to humans
Houssein A Sater
 
Dr. Jay Calvert - Vaccination Against a Recently Emerged Virulent PRRS Virus ...
Dr. Jay Calvert - Vaccination Against a Recently Emerged Virulent PRRS Virus ...Dr. Jay Calvert - Vaccination Against a Recently Emerged Virulent PRRS Virus ...
Dr. Jay Calvert - Vaccination Against a Recently Emerged Virulent PRRS Virus ...
John Blue
 
Rebecca Pentecost DVM: PLAA 2011 Keynote Slides
Rebecca Pentecost DVM: PLAA 2011 Keynote SlidesRebecca Pentecost DVM: PLAA 2011 Keynote Slides
Rebecca Pentecost DVM: PLAA 2011 Keynote Slides
RJ Stangherlin
 
Dr. Rebecca Pentecost: Pennsylvania Llama and Alpaca Association 2011
Dr. Rebecca Pentecost: Pennsylvania Llama and Alpaca Association 2011 Dr. Rebecca Pentecost: Pennsylvania Llama and Alpaca Association 2011
Dr. Rebecca Pentecost: Pennsylvania Llama and Alpaca Association 2011
changingconnections
 
Provenge (Sipuleucel T)
Provenge (Sipuleucel T)Provenge (Sipuleucel T)
Provenge (Sipuleucel T)Cytokinine
 
Provenge (sipuleucel t)
Provenge (sipuleucel t)Provenge (sipuleucel t)
Provenge (sipuleucel t)Vinblast
 
Garey-Austin-ELC-Presentation-022416.pptx
Garey-Austin-ELC-Presentation-022416.pptxGarey-Austin-ELC-Presentation-022416.pptx
Garey-Austin-ELC-Presentation-022416.pptx
Sahil922200
 
2014 07 ismb personalized medicine
2014 07 ismb personalized medicine2014 07 ismb personalized medicine
2014 07 ismb personalized medicine
University of California, San Francisco
 
Dr. Sid Thakur - Antimicrobial Resistance: Do We Know Everything?
Dr. Sid Thakur - Antimicrobial Resistance: Do We Know Everything?Dr. Sid Thakur - Antimicrobial Resistance: Do We Know Everything?
Dr. Sid Thakur - Antimicrobial Resistance: Do We Know Everything?
John Blue
 
Dr. Jack Dekkers - Update on the host genetics of resistance to porcine diseases
Dr. Jack Dekkers - Update on the host genetics of resistance to porcine diseasesDr. Jack Dekkers - Update on the host genetics of resistance to porcine diseases
Dr. Jack Dekkers - Update on the host genetics of resistance to porcine diseases
John Blue
 
Immunotherapy and Recurrent Ovarian Cancer: Time for New Paradigms!
Immunotherapy and Recurrent Ovarian Cancer: Time for New Paradigms!Immunotherapy and Recurrent Ovarian Cancer: Time for New Paradigms!
Immunotherapy and Recurrent Ovarian Cancer: Time for New Paradigms!
National Ovarian Cancer Coalition
 
Advances and Applications Enabled by Single Cell Technology
Advances and Applications Enabled by Single Cell TechnologyAdvances and Applications Enabled by Single Cell Technology
Advances and Applications Enabled by Single Cell Technology
QIAGEN
 
Dr. Randall Prather - PRRS Resistant Pigs
Dr. Randall Prather - PRRS Resistant PigsDr. Randall Prather - PRRS Resistant Pigs
Dr. Randall Prather - PRRS Resistant Pigs
John Blue
 

Similar to Dr. Graham Plastow - Resilience and PRRS in a natural disease challenge model (20)

Dr. Jack Dekkers and Dr. Bob Rowland - Introduction of the Program
Dr. Jack Dekkers and Dr. Bob Rowland - Introduction of the ProgramDr. Jack Dekkers and Dr. Bob Rowland - Introduction of the Program
Dr. Jack Dekkers and Dr. Bob Rowland - Introduction of the Program
 
Dr. Jack Dekkers - Using genetic selection and genomics to combat infectious ...
Dr. Jack Dekkers - Using genetic selection and genomics to combat infectious ...Dr. Jack Dekkers - Using genetic selection and genomics to combat infectious ...
Dr. Jack Dekkers - Using genetic selection and genomics to combat infectious ...
 
Dr. Jack Dekkers - Genetics of Host Resistance to PRRS and PCV2
Dr. Jack Dekkers - Genetics of Host Resistance to PRRS and PCV2Dr. Jack Dekkers - Genetics of Host Resistance to PRRS and PCV2
Dr. Jack Dekkers - Genetics of Host Resistance to PRRS and PCV2
 
Dr. Andrea Wilson - New PRRS disease phenotypes as vaccine and genetic improv...
Dr. Andrea Wilson - New PRRS disease phenotypes as vaccine and genetic improv...Dr. Andrea Wilson - New PRRS disease phenotypes as vaccine and genetic improv...
Dr. Andrea Wilson - New PRRS disease phenotypes as vaccine and genetic improv...
 
Developing diagnostic test for plant, human and animal diseases
Developing diagnostic test for plant, human and animal diseasesDeveloping diagnostic test for plant, human and animal diseases
Developing diagnostic test for plant, human and animal diseases
 
A Vaccine Approach against HIV-1, Manufacturing Env proteins: from Bench to B...
A Vaccine Approach against HIV-1, Manufacturing Env proteins: from Bench to B...A Vaccine Approach against HIV-1, Manufacturing Env proteins: from Bench to B...
A Vaccine Approach against HIV-1, Manufacturing Env proteins: from Bench to B...
 
Cancer vaccine from mice to humans
Cancer vaccine from mice to humansCancer vaccine from mice to humans
Cancer vaccine from mice to humans
 
Dr. Jay Calvert - Vaccination Against a Recently Emerged Virulent PRRS Virus ...
Dr. Jay Calvert - Vaccination Against a Recently Emerged Virulent PRRS Virus ...Dr. Jay Calvert - Vaccination Against a Recently Emerged Virulent PRRS Virus ...
Dr. Jay Calvert - Vaccination Against a Recently Emerged Virulent PRRS Virus ...
 
Rebecca Pentecost DVM: PLAA 2011 Keynote Slides
Rebecca Pentecost DVM: PLAA 2011 Keynote SlidesRebecca Pentecost DVM: PLAA 2011 Keynote Slides
Rebecca Pentecost DVM: PLAA 2011 Keynote Slides
 
Dr. Rebecca Pentecost: Pennsylvania Llama and Alpaca Association 2011
Dr. Rebecca Pentecost: Pennsylvania Llama and Alpaca Association 2011 Dr. Rebecca Pentecost: Pennsylvania Llama and Alpaca Association 2011
Dr. Rebecca Pentecost: Pennsylvania Llama and Alpaca Association 2011
 
Provenge (Sipuleucel T)
Provenge (Sipuleucel T)Provenge (Sipuleucel T)
Provenge (Sipuleucel T)
 
Provenge (sipuleucel t)
Provenge (sipuleucel t)Provenge (sipuleucel t)
Provenge (sipuleucel t)
 
Garey-Austin-ELC-Presentation-022416.pptx
Garey-Austin-ELC-Presentation-022416.pptxGarey-Austin-ELC-Presentation-022416.pptx
Garey-Austin-ELC-Presentation-022416.pptx
 
2014 07 ismb personalized medicine
2014 07 ismb personalized medicine2014 07 ismb personalized medicine
2014 07 ismb personalized medicine
 
Dr. Sid Thakur - Antimicrobial Resistance: Do We Know Everything?
Dr. Sid Thakur - Antimicrobial Resistance: Do We Know Everything?Dr. Sid Thakur - Antimicrobial Resistance: Do We Know Everything?
Dr. Sid Thakur - Antimicrobial Resistance: Do We Know Everything?
 
Dr. Jack Dekkers - Update on the host genetics of resistance to porcine diseases
Dr. Jack Dekkers - Update on the host genetics of resistance to porcine diseasesDr. Jack Dekkers - Update on the host genetics of resistance to porcine diseases
Dr. Jack Dekkers - Update on the host genetics of resistance to porcine diseases
 
Immunotherapy and Recurrent Ovarian Cancer: Time for New Paradigms!
Immunotherapy and Recurrent Ovarian Cancer: Time for New Paradigms!Immunotherapy and Recurrent Ovarian Cancer: Time for New Paradigms!
Immunotherapy and Recurrent Ovarian Cancer: Time for New Paradigms!
 
LP_ThesisDefense
LP_ThesisDefenseLP_ThesisDefense
LP_ThesisDefense
 
Advances and Applications Enabled by Single Cell Technology
Advances and Applications Enabled by Single Cell TechnologyAdvances and Applications Enabled by Single Cell Technology
Advances and Applications Enabled by Single Cell Technology
 
Dr. Randall Prather - PRRS Resistant Pigs
Dr. Randall Prather - PRRS Resistant PigsDr. Randall Prather - PRRS Resistant Pigs
Dr. Randall Prather - PRRS Resistant Pigs
 

More from John Blue

Jordan Hoewischer - OACI Farmer Certification Program
Jordan Hoewischer - OACI Farmer Certification ProgramJordan Hoewischer - OACI Farmer Certification Program
Jordan Hoewischer - OACI Farmer Certification Program
John Blue
 
Fred Yoder - No-till and Climate Change: Fact, Fiction, and Ignorance
Fred Yoder - No-till and Climate Change: Fact, Fiction, and IgnoranceFred Yoder - No-till and Climate Change: Fact, Fiction, and Ignorance
Fred Yoder - No-till and Climate Change: Fact, Fiction, and Ignorance
John Blue
 
Dr. John Grove - Fifty Years Of No-till Research In Kentucky
Dr. John Grove - Fifty Years Of No-till Research In KentuckyDr. John Grove - Fifty Years Of No-till Research In Kentucky
Dr. John Grove - Fifty Years Of No-till Research In Kentucky
John Blue
 
Dr. Warren Dick - Pioneering No-till Research Since 1962
Dr. Warren Dick - Pioneering No-till Research Since 1962Dr. Warren Dick - Pioneering No-till Research Since 1962
Dr. Warren Dick - Pioneering No-till Research Since 1962
John Blue
 
Dr. Christine Sprunger - The role that roots play in building soil organic ma...
Dr. Christine Sprunger - The role that roots play in building soil organic ma...Dr. Christine Sprunger - The role that roots play in building soil organic ma...
Dr. Christine Sprunger - The role that roots play in building soil organic ma...
John Blue
 
Dr. Leonardo Deiss - Stratification, the Role of Roots, and Yield Trends afte...
Dr. Leonardo Deiss - Stratification, the Role of Roots, and Yield Trends afte...Dr. Leonardo Deiss - Stratification, the Role of Roots, and Yield Trends afte...
Dr. Leonardo Deiss - Stratification, the Role of Roots, and Yield Trends afte...
John Blue
 
Dr. Steve Culman - No-Till Yield Data Analysis
Dr. Steve Culman - No-Till Yield Data AnalysisDr. Steve Culman - No-Till Yield Data Analysis
Dr. Steve Culman - No-Till Yield Data Analysis
John Blue
 
Alan Sundermeier and Dr. Vinayak Shedekar - Soil biological Response to BMPs
Alan Sundermeier and Dr. Vinayak Shedekar - Soil biological Response to BMPs Alan Sundermeier and Dr. Vinayak Shedekar - Soil biological Response to BMPs
Alan Sundermeier and Dr. Vinayak Shedekar - Soil biological Response to BMPs
John Blue
 
Dr. Curtis Young - Attracting And Protecting Pollinators
 Dr. Curtis Young - Attracting And Protecting Pollinators Dr. Curtis Young - Attracting And Protecting Pollinators
Dr. Curtis Young - Attracting And Protecting Pollinators
John Blue
 
Garth Ruff - Alternative Forages
Garth Ruff - Alternative Forages Garth Ruff - Alternative Forages
Garth Ruff - Alternative Forages
John Blue
 
Sarah Noggle - Cover Crop Decision Tool Selector
 Sarah Noggle - Cover Crop Decision Tool Selector Sarah Noggle - Cover Crop Decision Tool Selector
Sarah Noggle - Cover Crop Decision Tool Selector
John Blue
 
Jim Belt - Hemp Regulations
Jim Belt - Hemp RegulationsJim Belt - Hemp Regulations
Jim Belt - Hemp Regulations
John Blue
 
John Barker - UAVs: Where Are We And What's Next
John Barker - UAVs: Where Are We And What's NextJohn Barker - UAVs: Where Are We And What's Next
John Barker - UAVs: Where Are We And What's Next
John Blue
 
Dr. Rajbir Bajwa - Medical uses of Marijuana
 Dr. Rajbir Bajwa - Medical uses of Marijuana Dr. Rajbir Bajwa - Medical uses of Marijuana
Dr. Rajbir Bajwa - Medical uses of Marijuana
John Blue
 
Dr. Jeff Stachler - Setting up a Corn and Soybean Herbicide Program with Cove...
Dr. Jeff Stachler - Setting up a Corn and Soybean Herbicide Program with Cove...Dr. Jeff Stachler - Setting up a Corn and Soybean Herbicide Program with Cove...
Dr. Jeff Stachler - Setting up a Corn and Soybean Herbicide Program with Cove...
John Blue
 
Dr. Chad Penn - Developing A New Approach To Soil Phosphorus Testing And Reco...
Dr. Chad Penn - Developing A New Approach To Soil Phosphorus Testing And Reco...Dr. Chad Penn - Developing A New Approach To Soil Phosphorus Testing And Reco...
Dr. Chad Penn - Developing A New Approach To Soil Phosphorus Testing And Reco...
John Blue
 
Jim Hoorman - Dealing with Cover Crops after Preventative Planting
Jim Hoorman - Dealing with Cover Crops after Preventative PlantingJim Hoorman - Dealing with Cover Crops after Preventative Planting
Jim Hoorman - Dealing with Cover Crops after Preventative Planting
John Blue
 
Dr. Sjoerd Duiker - Dealing with Poor Soil Structure and Soil Compaction
Dr. Sjoerd Duiker - Dealing with Poor Soil Structure and Soil Compaction Dr. Sjoerd Duiker - Dealing with Poor Soil Structure and Soil Compaction
Dr. Sjoerd Duiker - Dealing with Poor Soil Structure and Soil Compaction
John Blue
 
Christine Brown - Canadian Livestock Producers Efforts to Improve Water Quality
Christine Brown - Canadian Livestock Producers Efforts to Improve Water QualityChristine Brown - Canadian Livestock Producers Efforts to Improve Water Quality
Christine Brown - Canadian Livestock Producers Efforts to Improve Water Quality
John Blue
 
Dr. Lee Briese - Details Matter (includes details about soil, equipment, cove...
Dr. Lee Briese - Details Matter (includes details about soil, equipment, cove...Dr. Lee Briese - Details Matter (includes details about soil, equipment, cove...
Dr. Lee Briese - Details Matter (includes details about soil, equipment, cove...
John Blue
 

More from John Blue (20)

Jordan Hoewischer - OACI Farmer Certification Program
Jordan Hoewischer - OACI Farmer Certification ProgramJordan Hoewischer - OACI Farmer Certification Program
Jordan Hoewischer - OACI Farmer Certification Program
 
Fred Yoder - No-till and Climate Change: Fact, Fiction, and Ignorance
Fred Yoder - No-till and Climate Change: Fact, Fiction, and IgnoranceFred Yoder - No-till and Climate Change: Fact, Fiction, and Ignorance
Fred Yoder - No-till and Climate Change: Fact, Fiction, and Ignorance
 
Dr. John Grove - Fifty Years Of No-till Research In Kentucky
Dr. John Grove - Fifty Years Of No-till Research In KentuckyDr. John Grove - Fifty Years Of No-till Research In Kentucky
Dr. John Grove - Fifty Years Of No-till Research In Kentucky
 
Dr. Warren Dick - Pioneering No-till Research Since 1962
Dr. Warren Dick - Pioneering No-till Research Since 1962Dr. Warren Dick - Pioneering No-till Research Since 1962
Dr. Warren Dick - Pioneering No-till Research Since 1962
 
Dr. Christine Sprunger - The role that roots play in building soil organic ma...
Dr. Christine Sprunger - The role that roots play in building soil organic ma...Dr. Christine Sprunger - The role that roots play in building soil organic ma...
Dr. Christine Sprunger - The role that roots play in building soil organic ma...
 
Dr. Leonardo Deiss - Stratification, the Role of Roots, and Yield Trends afte...
Dr. Leonardo Deiss - Stratification, the Role of Roots, and Yield Trends afte...Dr. Leonardo Deiss - Stratification, the Role of Roots, and Yield Trends afte...
Dr. Leonardo Deiss - Stratification, the Role of Roots, and Yield Trends afte...
 
Dr. Steve Culman - No-Till Yield Data Analysis
Dr. Steve Culman - No-Till Yield Data AnalysisDr. Steve Culman - No-Till Yield Data Analysis
Dr. Steve Culman - No-Till Yield Data Analysis
 
Alan Sundermeier and Dr. Vinayak Shedekar - Soil biological Response to BMPs
Alan Sundermeier and Dr. Vinayak Shedekar - Soil biological Response to BMPs Alan Sundermeier and Dr. Vinayak Shedekar - Soil biological Response to BMPs
Alan Sundermeier and Dr. Vinayak Shedekar - Soil biological Response to BMPs
 
Dr. Curtis Young - Attracting And Protecting Pollinators
 Dr. Curtis Young - Attracting And Protecting Pollinators Dr. Curtis Young - Attracting And Protecting Pollinators
Dr. Curtis Young - Attracting And Protecting Pollinators
 
Garth Ruff - Alternative Forages
Garth Ruff - Alternative Forages Garth Ruff - Alternative Forages
Garth Ruff - Alternative Forages
 
Sarah Noggle - Cover Crop Decision Tool Selector
 Sarah Noggle - Cover Crop Decision Tool Selector Sarah Noggle - Cover Crop Decision Tool Selector
Sarah Noggle - Cover Crop Decision Tool Selector
 
Jim Belt - Hemp Regulations
Jim Belt - Hemp RegulationsJim Belt - Hemp Regulations
Jim Belt - Hemp Regulations
 
John Barker - UAVs: Where Are We And What's Next
John Barker - UAVs: Where Are We And What's NextJohn Barker - UAVs: Where Are We And What's Next
John Barker - UAVs: Where Are We And What's Next
 
Dr. Rajbir Bajwa - Medical uses of Marijuana
 Dr. Rajbir Bajwa - Medical uses of Marijuana Dr. Rajbir Bajwa - Medical uses of Marijuana
Dr. Rajbir Bajwa - Medical uses of Marijuana
 
Dr. Jeff Stachler - Setting up a Corn and Soybean Herbicide Program with Cove...
Dr. Jeff Stachler - Setting up a Corn and Soybean Herbicide Program with Cove...Dr. Jeff Stachler - Setting up a Corn and Soybean Herbicide Program with Cove...
Dr. Jeff Stachler - Setting up a Corn and Soybean Herbicide Program with Cove...
 
Dr. Chad Penn - Developing A New Approach To Soil Phosphorus Testing And Reco...
Dr. Chad Penn - Developing A New Approach To Soil Phosphorus Testing And Reco...Dr. Chad Penn - Developing A New Approach To Soil Phosphorus Testing And Reco...
Dr. Chad Penn - Developing A New Approach To Soil Phosphorus Testing And Reco...
 
Jim Hoorman - Dealing with Cover Crops after Preventative Planting
Jim Hoorman - Dealing with Cover Crops after Preventative PlantingJim Hoorman - Dealing with Cover Crops after Preventative Planting
Jim Hoorman - Dealing with Cover Crops after Preventative Planting
 
Dr. Sjoerd Duiker - Dealing with Poor Soil Structure and Soil Compaction
Dr. Sjoerd Duiker - Dealing with Poor Soil Structure and Soil Compaction Dr. Sjoerd Duiker - Dealing with Poor Soil Structure and Soil Compaction
Dr. Sjoerd Duiker - Dealing with Poor Soil Structure and Soil Compaction
 
Christine Brown - Canadian Livestock Producers Efforts to Improve Water Quality
Christine Brown - Canadian Livestock Producers Efforts to Improve Water QualityChristine Brown - Canadian Livestock Producers Efforts to Improve Water Quality
Christine Brown - Canadian Livestock Producers Efforts to Improve Water Quality
 
Dr. Lee Briese - Details Matter (includes details about soil, equipment, cove...
Dr. Lee Briese - Details Matter (includes details about soil, equipment, cove...Dr. Lee Briese - Details Matter (includes details about soil, equipment, cove...
Dr. Lee Briese - Details Matter (includes details about soil, equipment, cove...
 

Recently uploaded

Nutraceutical market, scope and growth: Herbal drug technology
Nutraceutical market, scope and growth: Herbal drug technologyNutraceutical market, scope and growth: Herbal drug technology
Nutraceutical market, scope and growth: Herbal drug technology
Lokesh Patil
 
insect taxonomy importance systematics and classification
insect taxonomy importance systematics and classificationinsect taxonomy importance systematics and classification
insect taxonomy importance systematics and classification
anitaento25
 
ESR_factors_affect-clinic significance-Pathysiology.pptx
ESR_factors_affect-clinic significance-Pathysiology.pptxESR_factors_affect-clinic significance-Pathysiology.pptx
ESR_factors_affect-clinic significance-Pathysiology.pptx
muralinath2
 
filosofia boliviana introducción jsjdjd.pptx
filosofia boliviana introducción jsjdjd.pptxfilosofia boliviana introducción jsjdjd.pptx
filosofia boliviana introducción jsjdjd.pptx
IvanMallco1
 
In silico drugs analogue design: novobiocin analogues.pptx
In silico drugs analogue design: novobiocin analogues.pptxIn silico drugs analogue design: novobiocin analogues.pptx
In silico drugs analogue design: novobiocin analogues.pptx
AlaminAfendy1
 
Lab report on liquid viscosity of glycerin
Lab report on liquid viscosity of glycerinLab report on liquid viscosity of glycerin
Lab report on liquid viscosity of glycerin
ossaicprecious19
 
Seminar of U.V. Spectroscopy by SAMIR PANDA
 Seminar of U.V. Spectroscopy by SAMIR PANDA Seminar of U.V. Spectroscopy by SAMIR PANDA
Seminar of U.V. Spectroscopy by SAMIR PANDA
SAMIR PANDA
 
Deep Behavioral Phenotyping in Systems Neuroscience for Functional Atlasing a...
Deep Behavioral Phenotyping in Systems Neuroscience for Functional Atlasing a...Deep Behavioral Phenotyping in Systems Neuroscience for Functional Atlasing a...
Deep Behavioral Phenotyping in Systems Neuroscience for Functional Atlasing a...
Ana Luísa Pinho
 
NuGOweek 2024 Ghent - programme - final version
NuGOweek 2024 Ghent - programme - final versionNuGOweek 2024 Ghent - programme - final version
NuGOweek 2024 Ghent - programme - final version
pablovgd
 
Citrus Greening Disease and its Management
Citrus Greening Disease and its ManagementCitrus Greening Disease and its Management
Citrus Greening Disease and its Management
subedisuryaofficial
 
Body fluids_tonicity_dehydration_hypovolemia_hypervolemia.pptx
Body fluids_tonicity_dehydration_hypovolemia_hypervolemia.pptxBody fluids_tonicity_dehydration_hypovolemia_hypervolemia.pptx
Body fluids_tonicity_dehydration_hypovolemia_hypervolemia.pptx
muralinath2
 
Richard's entangled aventures in wonderland
Richard's entangled aventures in wonderlandRichard's entangled aventures in wonderland
Richard's entangled aventures in wonderland
Richard Gill
 
Richard's aventures in two entangled wonderlands
Richard's aventures in two entangled wonderlandsRichard's aventures in two entangled wonderlands
Richard's aventures in two entangled wonderlands
Richard Gill
 
The ASGCT Annual Meeting was packed with exciting progress in the field advan...
The ASGCT Annual Meeting was packed with exciting progress in the field advan...The ASGCT Annual Meeting was packed with exciting progress in the field advan...
The ASGCT Annual Meeting was packed with exciting progress in the field advan...
Health Advances
 
Circulatory system_ Laplace law. Ohms law.reynaults law,baro-chemo-receptors-...
Circulatory system_ Laplace law. Ohms law.reynaults law,baro-chemo-receptors-...Circulatory system_ Laplace law. Ohms law.reynaults law,baro-chemo-receptors-...
Circulatory system_ Laplace law. Ohms law.reynaults law,baro-chemo-receptors-...
muralinath2
 
Observation of Io’s Resurfacing via Plume Deposition Using Ground-based Adapt...
Observation of Io’s Resurfacing via Plume Deposition Using Ground-based Adapt...Observation of Io’s Resurfacing via Plume Deposition Using Ground-based Adapt...
Observation of Io’s Resurfacing via Plume Deposition Using Ground-based Adapt...
Sérgio Sacani
 
RNA INTERFERENCE: UNRAVELING GENETIC SILENCING
RNA INTERFERENCE: UNRAVELING GENETIC SILENCINGRNA INTERFERENCE: UNRAVELING GENETIC SILENCING
RNA INTERFERENCE: UNRAVELING GENETIC SILENCING
AADYARAJPANDEY1
 
GBSN - Microbiology (Lab 4) Culture Media
GBSN - Microbiology (Lab 4) Culture MediaGBSN - Microbiology (Lab 4) Culture Media
GBSN - Microbiology (Lab 4) Culture Media
Areesha Ahmad
 
role of pramana in research.pptx in science
role of pramana in research.pptx in sciencerole of pramana in research.pptx in science
role of pramana in research.pptx in science
sonaliswain16
 
Hemostasis_importance& clinical significance.pptx
Hemostasis_importance& clinical significance.pptxHemostasis_importance& clinical significance.pptx
Hemostasis_importance& clinical significance.pptx
muralinath2
 

Recently uploaded (20)

Nutraceutical market, scope and growth: Herbal drug technology
Nutraceutical market, scope and growth: Herbal drug technologyNutraceutical market, scope and growth: Herbal drug technology
Nutraceutical market, scope and growth: Herbal drug technology
 
insect taxonomy importance systematics and classification
insect taxonomy importance systematics and classificationinsect taxonomy importance systematics and classification
insect taxonomy importance systematics and classification
 
ESR_factors_affect-clinic significance-Pathysiology.pptx
ESR_factors_affect-clinic significance-Pathysiology.pptxESR_factors_affect-clinic significance-Pathysiology.pptx
ESR_factors_affect-clinic significance-Pathysiology.pptx
 
filosofia boliviana introducción jsjdjd.pptx
filosofia boliviana introducción jsjdjd.pptxfilosofia boliviana introducción jsjdjd.pptx
filosofia boliviana introducción jsjdjd.pptx
 
In silico drugs analogue design: novobiocin analogues.pptx
In silico drugs analogue design: novobiocin analogues.pptxIn silico drugs analogue design: novobiocin analogues.pptx
In silico drugs analogue design: novobiocin analogues.pptx
 
Lab report on liquid viscosity of glycerin
Lab report on liquid viscosity of glycerinLab report on liquid viscosity of glycerin
Lab report on liquid viscosity of glycerin
 
Seminar of U.V. Spectroscopy by SAMIR PANDA
 Seminar of U.V. Spectroscopy by SAMIR PANDA Seminar of U.V. Spectroscopy by SAMIR PANDA
Seminar of U.V. Spectroscopy by SAMIR PANDA
 
Deep Behavioral Phenotyping in Systems Neuroscience for Functional Atlasing a...
Deep Behavioral Phenotyping in Systems Neuroscience for Functional Atlasing a...Deep Behavioral Phenotyping in Systems Neuroscience for Functional Atlasing a...
Deep Behavioral Phenotyping in Systems Neuroscience for Functional Atlasing a...
 
NuGOweek 2024 Ghent - programme - final version
NuGOweek 2024 Ghent - programme - final versionNuGOweek 2024 Ghent - programme - final version
NuGOweek 2024 Ghent - programme - final version
 
Citrus Greening Disease and its Management
Citrus Greening Disease and its ManagementCitrus Greening Disease and its Management
Citrus Greening Disease and its Management
 
Body fluids_tonicity_dehydration_hypovolemia_hypervolemia.pptx
Body fluids_tonicity_dehydration_hypovolemia_hypervolemia.pptxBody fluids_tonicity_dehydration_hypovolemia_hypervolemia.pptx
Body fluids_tonicity_dehydration_hypovolemia_hypervolemia.pptx
 
Richard's entangled aventures in wonderland
Richard's entangled aventures in wonderlandRichard's entangled aventures in wonderland
Richard's entangled aventures in wonderland
 
Richard's aventures in two entangled wonderlands
Richard's aventures in two entangled wonderlandsRichard's aventures in two entangled wonderlands
Richard's aventures in two entangled wonderlands
 
The ASGCT Annual Meeting was packed with exciting progress in the field advan...
The ASGCT Annual Meeting was packed with exciting progress in the field advan...The ASGCT Annual Meeting was packed with exciting progress in the field advan...
The ASGCT Annual Meeting was packed with exciting progress in the field advan...
 
Circulatory system_ Laplace law. Ohms law.reynaults law,baro-chemo-receptors-...
Circulatory system_ Laplace law. Ohms law.reynaults law,baro-chemo-receptors-...Circulatory system_ Laplace law. Ohms law.reynaults law,baro-chemo-receptors-...
Circulatory system_ Laplace law. Ohms law.reynaults law,baro-chemo-receptors-...
 
Observation of Io’s Resurfacing via Plume Deposition Using Ground-based Adapt...
Observation of Io’s Resurfacing via Plume Deposition Using Ground-based Adapt...Observation of Io’s Resurfacing via Plume Deposition Using Ground-based Adapt...
Observation of Io’s Resurfacing via Plume Deposition Using Ground-based Adapt...
 
RNA INTERFERENCE: UNRAVELING GENETIC SILENCING
RNA INTERFERENCE: UNRAVELING GENETIC SILENCINGRNA INTERFERENCE: UNRAVELING GENETIC SILENCING
RNA INTERFERENCE: UNRAVELING GENETIC SILENCING
 
GBSN - Microbiology (Lab 4) Culture Media
GBSN - Microbiology (Lab 4) Culture MediaGBSN - Microbiology (Lab 4) Culture Media
GBSN - Microbiology (Lab 4) Culture Media
 
role of pramana in research.pptx in science
role of pramana in research.pptx in sciencerole of pramana in research.pptx in science
role of pramana in research.pptx in science
 
Hemostasis_importance& clinical significance.pptx
Hemostasis_importance& clinical significance.pptxHemostasis_importance& clinical significance.pptx
Hemostasis_importance& clinical significance.pptx
 

Dr. Graham Plastow - Resilience and PRRS in a natural disease challenge model

  • 1. Resilience and PRRS in a natural disease challenge model Graham Plastow University of Alberta Chicago, December 2nd 2017
  • 2. Application of Genomics to Improve Disease Resilience and Sustainability in Pork Production Project Leaders: Michael Dyck (U Alberta), John Harding (U Saskatchewan), Bob Kemp (PigGen Canada)
  • 3. Application of Genomics to Improve Disease Resilience and Sustainability in Pork Production Project Leaders: Michael Dyck (U Alberta), John Harding (U Saskatchewan), Bob Kemp (PigGen Canada) Includes several components Vaccine response Salmonella challenge (Ab/Microbiome) Nutrition & Gut Health (Microbiome) PRRSV Pregnant Gilt Challenge e.g. Vet. Micro. 209: 114-123 (2017) Organoid models and Natural Challenge Model
  • 4. A Natural Challenge Model for Disease Resilience in Pigs Jack Dekkers, John Harding, Frederic Fortin, PigGen Canada, Michael Dyck, Graham Plastow Andrea Wilson, Bonnie Mallard, Claire Rogel-Gaillard, Ben Willing, Catherine Field Austin Putz, Jiehan Lim, Ziqi Yang
  • 5. What is Resilience? • Definition of Resilience….. – “the capacity to recover quickly from difficulties; toughness.” Oxford Dictionary https://en.oxforddictionaries.com • Disease Resilience….. – combination of resistance and tolerance to diseases….animal’s ability to remain productive despite being disease-challenged – The ability of pigs to respond to pathogens in a way that minimizes the impact of disease
  • 6. •Objectives 1. Establish a natural challenge model for grow-finish pigs 2. Determine the genetic basis of disease resilience in pigs 3. Develop predictors of resilience that can be obtained at a young age in a high-health bio-secure environment A Natural Challenge Model for Disease Resilience in Pigs
  • 7. • PRRS is the most significant disease but it is not only PRRSV • Numerous other pathogens are commonly isolated along with PRRS virus from affected nursery or finishing pigs. Other bacteria such as Streptococcus suis, Escherichia coli, Salmonella cholerasuis, Haemophilus parasuis, and Mycoplasma hyopneumoniae have been reported, as well as viruses such as porcine respiratory coronavirus and swine influenza virus. Dee, Merck Veterinary Manual, http://www.merckvetmanual.com/generalized-conditions/porcine-reproductive-and- respiratory-syndrome/overview-of-porcine-reproductive-and-respiratory-syndrome Motivation?
  • 8. Health is the Biggest Opportunity for Animal Genomics  zoonoses (60% of EIDs) Adapted from a slide by Dan Barreda The British Pig Association http://www.britishpigs.org.uk/modern2.htm
  • 9. High health Lower health Selection for genetic potential for disease resilience Health & Growth Performance ? INTRODUCTION
  • 10. • Established by introducing selected “seeder pigs” from different commercial farms with first few batches entering the model • Continuous flow • Each batch from a single company/herd • All are LW*LR barrows from high health herds • Weaned and transported to acclimation unit where samples are collected prior to challenge Natural Challenge (Pig & Sample Flow)
  • 11. 60-75 LW/LR barrows/batch High Health Multiplier Farm weaned - 21 days old transported Nursery 1 (2 weeks) Quarantine and acclimatization CDPQ Test Station (4 weeks) Nursery CDPQ Test Station (16 weeks) Grower & finisher transferred Severity of disease challenge Clean Mild challenge Severe challenge Natural Challenge (Pig & Sample Flow) Blood 1 – 26 day-old Blood 3 – 56 days (Week 2 post-exposure) Blood 4 – 84 days (Week 6 post-exposure) Exposure to seeder pigs at 42 days DNA Samples - Genotyping 660,000 SNPs Target 3,300 pigs
  • 12. N Cook, Alberta Agriculture & Forestry, Lacombe J-P Laforest, Université Laval F Fortin, CDPQ, QC
  • 13. Natural Challenge (Pig & Sample Flow) 60-75 barrows/batch from High Health Multiplier Farm Weaned at 21 days old transported CRSAD Building (3 weeks) Nursery I D26 – Blood 1 D42 – Blood 2 & exit Nursery I CDPQ Test Station (4 weeks) Nursery II D56 – Blood 3 CDPQ Test Station (16 weeks) Grower & Finisher D86 – Blood 4 D120B1-8/D166B9-on – Blood 5 transferred Blood Samples collected 1 HIR, DRAA, CBC, WBT, Serology 2 HIR, Serology, microbiome 3 CBC, Nab, IgG, WBT, microbiome 4 CBC, IgG, WBT, Serology, microbiome 5 Serology 6 WBT, Serology (sick & healthy)
  • 14. Overview - Data Quarantine Nursery Immune Response •HIR •DRAA •CBC •Blood Stimulation •Phagocytosis Blood Transcriptome Blood Metabolome Blood Proteome Gut Microbiome Natural Challenge Facility Growth Feed/ Water Intake Mortality/Morbidity Carcass/Ultrasound Disease Diagnostics Blood Transcriptome Gut Microbiome March 14, 2017 Midwest 2017 14 Deliverables Phenotypic Prediction of Resilience Genetic Prediction of Resilience Trait: • Parameters • Architecture • Mechanisms Integrated statistical and bioinformatic analyses Putz, A.M., Harding, J.C.S., Fortin, F., Plastow, G., Dekkers, J.C.M. (2017) A natural challenge model for disease resilience in wean-to-finish pigs. ASAS MidWest Meeting March 2017. J. Anim. Sci 95: supplement2, p.17. Sample bank
  • 15. Diseases March 14, 2017 Midwest 2017 15 Adapted from Dr. John Harding
  • 16. Lung lesion (Mycoplasma hyopneumoniae, complicated with PRRS & Streptococcus suis) Lung lesion (chronic stage of PRRS in grower) Lung lesion (Haemophilus parasuis in grower) Types of lung lesion found in dead pigs with respiratory signs NATURAL CHALLENGE Jiehan Lim
  • 17. Mortality Reasons % Lameness 10 Coughing 11 Unthrifty 5 Diarrhea red 1 grey/brown 19 yellow 7 Dermatitis 4 CNS 3 Respiratory 31 Arthritis 5 Inappetance 2 Cyanosis 2 Example Growth Curves # health treatments Blood 1 Blood 3 Blood 4 Disease exposure Average Mortality at 78 ± 2.3 days
  • 18. Predicting which Pigs are Resilient ? Immune Response Measures • Complete Blood Counts (UAlberta) ‒ CBC = Evaluates white blood cells, leukocytes, B cells, monocytes and acute phase proteins in pigs • High Immune Response Assay (UGuelph) ‒ HIR = Assesses adaptive immune response in pigs including: antibody-mediated and cell-mediated immune responses • Disease Resistance Assay for Animals (ULaval; USask) ‒ DRAA = Assess immune competence in pigs based on proliferation of peripheral blood mononuclear cells in pigs after stimulation by mitogens ‒ Total Immunoglobulin (IgG) & Natural antibodies (NAb) ELISA • Blood Transcriptome (UAlberta)
  • 19. Resilience Phenotype • Treatments • Disease diagnosis (qualitative) • Mortality • Growth • Feed Intake • Water Intake • Blood Transcriptome (Blood 3 and 4)
  • 20. Austin Putz Example Feed Intake Curves Poster #63
  • 21. Trait h2 Growth Nursery 0.45 + 0.07 Finish 0.26 + 0.07 Feed Intake 0.33 + 0.07 Gain/Feed 0.35 + 0.07 RFI 0.43 + 0.07 Treatments 0.14 + 0.07 Mortality Liability 0.26 + 0.07 Carcass Wt 0.31 + 0.07 Destron BF 0.52 + 0.08 Destron LD 0.40 + 0.08 Lean Yield 0.39 + 0.09 Trait Heritabilities
  • 22. Daily Fluctuation in FI as a Measure of Resilience Austin Putz Trait rg with MSE of FI Growth Finish -0.31 + 0.27 # Treatments 0.56 + 0.20 Mortality Liability 0.54 + 0.36 MSE of FI h2 = 0.22+ 0.07
  • 23. • A natural challenge model for characterization of disease resilience in pigs has been successfully established Conclusions 1 • MSE of FI shows promise as a measure of resilience. • Heritable variation in growth, feed intake curves, mortality, morbidity
  • 24. 3300 YXLR WEANER PIGS FROM HIGH-HEALTH HERDS BATCHES OF 60-75 PIGS/3 WEEKS 650K SNP genotypes Trait Genetics • Parameters • Architecture • Mechanisms Genetic Prediction of Resilience Phenotypic Prediction of Resilience PROJECT DELIVE- RABLES Potential BIOMARKERS collected on young healthy pigs Immune Response • High Immune Response • In vitro immune tests • Phagocytosis tests Blood Transcriptome Blood Metabolome Blood Proteome Gut Microbiome Integrated statistical and bioinformatic analyses NATURAL CHALLENGE FACILITYQUARANTINE NURSERY Continuous flow RESILIENCE PHENOTYPES Mortality/Morbidity Growth performance Feed intake Water intake Disease diagnostics Blood transcriptome Gut Microbiome Health treatments
  • 25. •Example - Complete Blood Counts (CBC)
  • 26. •Complete Blood Counts (CBC) Number of treatments
  • 27. Some initial results Difference in neutrophil/ lymphocyte % between R and S Deads not different at Bleed 1 Neutrophil % Lymphocyte % abab a bab
  • 28. Resilient vs Susceptible samples selected for qPCR Class Count Bleed 1 Bleed 2 Bleed 3 Resistant Neutrophils 4.8 12.1 9.4 Susceptible Neutrophils 3.8 14.0 13.5 Resistant Lymphocytes 6.3 7.8 9.4 Susceptible Lymphocytes 7.1 8.0 7.4 Resistant N/L 0.77 1.57 1.12 Susceptible N/L 0.55 1.86 1.91
  • 29. Using CBC for Prediction of Outcome Cycle 1 (n=391) predicts Cycle 2 (n=397) including dead Stepwise model accuracy 68.8% Predicted Resilient pigs in Cycle 2 Actual Resilient 40% versus 29% in Predicted Susceptible Grow 25g/day faster (all included) Ave treatment rate 0.5x less Mortality 0% versus 13% Work in progress – results highly dependent on assumptions and classification of resilient pigs in the training set.
  • 30. Blood Transcriptome and Resilience Differentially expressed genes identified in three different environments “predicting outcome” NC1 Genome dx.doi.org/10.1139/gen-2017-0074
  • 31. • A natural challenge model for characterization of disease resilience in pigs has been successfully established Conclusions 2 • Initial CBC shows initial promise as a predictor of phenotypic resilience. • Test different predictors with MSE of FI. • Genetic analysis, GWAS (660k)……………….
  • 32. Next? • Complete data collection (3,300 from 2,000 today) • Integrate analyses • Explore blood transcriptome (3’RNAseq), metabolome and proteome on 960 samples (14 batches) (USDA NIFA) • Explore infectivity (Andrea Wilson, RI) • The effect of environmental enrichment on the immune response and measures of disease resilience and welfare in pigs. (Yolande Seddon, U of SK) • Other opportunities – e.g. pen-side diagnostics

Editor's Notes

  1. Figure 1. Schematic overview of phenomics to develop genetic and phenotypic predictors of resilience. Red underlined text indicates phenomic data and information that will be generated in the proposed work, building on phenotypic and genotypic data that will be generated as part of the existing Genome Alberta and Genome Canada project, as well as in the FAANG project, in which a total of 3,500 healthy weaner pigs are first evaluated in a quarantine nursery and then entered in a natural challenge nursery-grow-finish research facility. Project data, analyses and results will both utilize and contribute to the FAANG project. Data collected only on a limited number of case-control animal Resilience, indicator, and intermediate –omics traits and their interrelationships
  2. International, industry, research partnerships